Quest Diagnostics (DGX) EPS (Basic) Growth (3y) (2012 - 2026)
Quest Diagnostics (DGX) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.92 Bn | 209.86 Bn | 8.34 Bn | 10.33% |
| 2 | Danaher | 140.37 Bn | 136.02 Bn | 3.61 Bn | -6.31% |
| 3 | Idexx Laboratories | 46.17 Bn | 45.97 Bn | 779.09 Mn | 16.67% |
| 4 | Agilent Technologies | 39.76 Bn | 37.96 Bn | 990.00 Mn | 5.62% |
| 5 | Iqvia Holdings | 39.41 Bn | 37.33 Bn | 1.44 Bn | -3.09% |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 30.07 Bn | 28.90 Bn | 770.00 Mn | 43.02% |
| 8 | Mettler Toledo International | 28.62 Bn | 28.56 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.15 Bn | 25.53 Bn | 1.03 Bn | 10.55% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 293.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.55% |
| Mar 31, 2026 | 7.68% |
| Dec 31, 2025 | 32.05% |
| Sep 30, 2025 | -1.25% |
| Jun 30, 2025 | 6.82% |
| Mar 31, 2025 | -12.05% |
| Dec 31, 2024 | -12.48% |
| Sep 30, 2024 | -20.29% |
| Jun 30, 2024 | -29.21% |
| Mar 31, 2024 | -20.28% |
| Jun 30, 2022 | 142.11% |
| Dec 31, 2017 | 278.91% |
| Dec 31, 2014 | 1.20% |
| Sep 30, 2013 | 103.54% |
| Jun 30, 2013 | 289.87% |
| Mar 31, 2013 | 34.60% |
| Dec 31, 2012 | -695.05% |
| Sep 30, 2012 | 120.60% |
| Jun 30, 2012 | 198.40% |
| Mar 31, 2012 | 26.04% |